Target intelligence / Profile preview

Bacterial cell wall synthesis enzyme in Cutibacterium acnes

Molecular classification
Enzyme (including glycosyltransferases, transpeptidases, etc.), Biosynthetic pathway
01

Overview

The cell wall synthesis enzymes in Cutibacterium acnes are responsible for constructing its unique peptidoglycan-rich cell wall, which enables the bacterium to survive on human skin and in anaerobic environments. The cell wall features distinct biochemical characteristics, such as peptide chains incorporating L-diaminopimelic acid and D-alanine, setting it apart from other Gram-positive bacteria[3]. This target is of particular therapeutic interest because inhibiting cell wall synthesis halts bacterial replication and disrupts biofilm formation, making it a principal focus for classic antibiotics and novel anti-acne treatments. Importantly, biofilm formation contributes to heightened resistance against antimicrobials, persistent inflammation, and device-associated infections, underscoring the medical significance of this target[2][3][5].

Other names
Cell wall biosynthesis in Cutibacterium acnesPeptidoglycan synthesis in Cutibacterium acnes
02

Mechanism of action

Inhibition of peptidoglycan crosslinking; Inhibition of glycosyltransferase enzymes; Inhibition of uridine diphosphate N-acetylglucosamine 2-epimerase (essential for cell wall sugar biosynthesis)

03

Biological functions

Cell divisionMaintenance of cell shapeBiofilm formationSurvival in hostile environmentsVirulence (persistence in tissue, immune evasion)
04

Disease associations

InfectionAcne vulgarisDevice-associated infections (prosthetic joints, cardiac devices)Other inflammatory diseases (e.g., sarcoidosis, chronic blepharitis)
05

Safety considerations

Antibiotic resistance (including biofilm-mediated resistance)Disruption of skin microbiota, leading to dysbiosisPotential adverse immune reactions
06

Interacting drugs

Beta-lactam antibiotics (penicillins, cephalosporins)

3 more in the full profile.

07

Biomarkers

Presence of Cutibacterium acnes DNA or proteins (diagnostic marker)Detection of biofilm-specific polysaccharides: poly-β(1-6)-N-acetylglucosamine (PNAG)Inflammatory markers: IL-8, IL-6, TNFα, GM-CSF in skin lesions

Beyond the preview

Go deeper on Bacterial cell wall synthesis enzyme in Cutibacterium acnes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bacterial cell wall synthesis enzyme in Cutibacterium acnes.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call